OTC Markets EXMKT - Delayed Quote USD
Affymax, Inc. (AFFY)
0.0008
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2013) | Current Year (2013) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.68 | -1.33 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2013) | Current Year (2013) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 6/30/2012 | 9/30/2012 | 12/31/2012 | 3/31/2013 |
|---|---|---|---|---|
| EPS Est. | -0.67 | -0.71 | -0.61 | -0.65 |
| EPS Actual | -0.89 | -0.68 | -0.63 | -0.9 |
| Difference | -0.22 | 0.03 | -0.02 | -0.24 |
| Surprise % | -32.84% | 4.49% | -3.21% | -37.25% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2013) | Current Year (2013) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Sep 2013) | Current Year (2013) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AFFY | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Downgrade | McNicoll Lewis Vlak: Sell | 3/19/2013 |
| Downgrade | Lazard: Buy to Neutral | 2/26/2013 |
| Downgrade | JMP Securities: Market Outperform to Market Underperform | 2/25/2013 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/25/2013 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/25/2013 |
| Downgrade | Stifel: Buy to Hold | 2/25/2013 |
Related Tickers
NNBP Nanobac Pharmaceuticals, Incorporated
0.0001
0.00%
ROTH PharmaRoth Labs, Inc.
0.0001
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
OGEN Oragenics, Inc.
0.1940
+3.74%
GALT Galectin Therapeutics Inc.
1.3400
+0.75%
TH.TO Theratechnologies Inc.
3.7350
-1.45%
RLMD Relmada Therapeutics, Inc.
0.6900
+82.54%
VIR Vir Biotechnology, Inc.
5.97
+2.93%